Pharmacy Benefits and Disease-Modifying Therapies
Neurology Minute · Anna Rehbein
February 17, 20222m 58s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Daniel Hartung discusses the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis.
Show references:
https://cp.neurology.org/content/12/1/36
https://www.neurology.org/podcast